OMICRON

Omicron is an infectious disease is caused by the variant of the Coronavirus(COVID-19)

INTRODUCTION

WHO designated the variant B.1.1.529 a variant of concern, named omicron, on the advice of WHO's (TAG-VE) Technical Advisory Group on Virus Evolution. This decision was based on the evidence presented to the TAG-VE that omicron has several mutations that may have an impact on how it behaves, for example, on how easily it spreads or the severity of illness it causes. Here is a summary of what is currently known.

CURRENT SITUATION ABOUT OMICRON

Researchers in South Africa and around the world are conducting studies to better understand many aspects of omicron and will continue to share the findings of these studies as they become available.

TRANSMITTABLE:

                                            It is not yet clear whether omicron is more transmissible compared to other variants, including Delta. The number of people testing positive has risen in areas of South Africa affects by this variant but epidemiologic studies are underway to understand if it is because of omicron.

SEVERITY OF DISEASE:

                                                         It is not yet clear whether infection with omicron causes more severe disease compared to infections with other variants, including Delta. Preliminary data severe disease compared to infections with other variants, including Delta. Preliminary data suggest that there are increasing rates of hospitalization in South Africa, but this may be due to increasing overall numbers of people becoming infected, rather than a result of specific infection with omicron are different from those from other variants. Initially reported infections were among university students-younger individuals who tend to have more mild disease-but understanding the level of severity of the omicron variant will take days to several weeks. All variants of covid-19, including the delta variant that is dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key.

 Omicron is more easily spread from person to person compared to other variants, including Delta. It can cause severe disease, death, further virus mutations. Omicron multiplies around 70 times faster than the Delta variant in the bronchi (lung airways). 

SYMPTOMS:

According to US CDC analysis, the five most common symptoms of the omicron variant are cough, fatigue, congestion, runny nose and generalized body ache. Recently, the UK-based Zoe covid app study added new symptoms such as nausea and loss of appetite.

Symptoms are classified in 1) Most common symptoms, 2) Less common symptoms and 3) Serious symptoms

Most Common Symptoms:

The most common symptoms for the Omicron are:

             * Fever 

             * Cough

             * Tiredness and 

             * Loss of taste or smell

Less Common Symptoms:

Less common symptoms for the Omicron are:

              * Sore throat 

              * Headache

              * Aches and Pains

              * Diarrhea

              * A rash on the skin  

              * Discolouration of fingers or toes               

              * Red or irritated eyes            

Serious Symptoms:

Serious symptoms for the Omicron are:

               * Difficulty breathing or shortness of breath 

               * Loss of speech 

                * Mobility 

               * Confusion 

               * Chest pain

If anyone has any of these symptoms then he/she should urgently take the COVID test.

                 

PRECAUTION:

To prevent infection and to slow transmission of OMICRON, do the following

*Wash your hand regularly with soap and water or clean them with an alcohol-based hand rub.

*Maintain at least 1meter distance between you and people coughing or sneezing

*Avoid touching your face 

*Cover your mouth and nose when coughing or sneezing

*Stay home if you feel unwell 

*Refrain from smoking and other activities that weaken the lungs 

*Practice physical distancing by avoiding unnecessary travel and staying away from large groups of people 

VACCINE

COVAXIN: 

                     

• India's first Indigenous COVID-19 Vaccine
• It included immune-potentiators, also known as vaccine adjuvants, which are added to the vaccine to increase and boost its immunogenicity.
• It is a 2-dose vaccination regime given 28 days apart.
• In the Phase 2 study, 380 participants of 12-65 years were enrolled. COVAXIN led to tolerable safety outcomes and enhanced humoral and cell-mediated immune responses. Know more about our phase 2 study.
• The purpose of this study is to evaluate the efficacy, safety, and immunogenicity of COVAXIN in volunteers aged > 18 years.

COVISHIELD:

BOOSTER DOSE:

                    

BOOSTER DOSE-https://youtu.be/up8HLRpF5OM

                    STAY HOME STAY SAFE

PRESENTED BY:

                  

                                                                      @INFOWEB